Copyright Reports & Markets. All rights reserved.

Global Lumiracoxib Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Lumiracoxib
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Lumiracoxib Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Min Purity Less Than 98%
    • 1.3.3 Min Purity 98%-99%
    • 1.3.4 Min Purity More Than 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Lumiracoxib Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Research
    • 1.4.3 Medical
  • 1.5 Global Lumiracoxib Market Size & Forecast
    • 1.5.1 Global Lumiracoxib Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Lumiracoxib Sales Quantity (2018-2029)
    • 1.5.3 Global Lumiracoxib Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Selleck Chemicals
    • 2.1.1 Selleck Chemicals Details
    • 2.1.2 Selleck Chemicals Major Business
    • 2.1.3 Selleck Chemicals Lumiracoxib Product and Services
    • 2.1.4 Selleck Chemicals Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Selleck Chemicals Recent Developments/Updates
  • 2.2 Abcam
    • 2.2.1 Abcam Details
    • 2.2.2 Abcam Major Business
    • 2.2.3 Abcam Lumiracoxib Product and Services
    • 2.2.4 Abcam Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Abcam Recent Developments/Updates
  • 2.3 Cayman Chemical
    • 2.3.1 Cayman Chemical Details
    • 2.3.2 Cayman Chemical Major Business
    • 2.3.3 Cayman Chemical Lumiracoxib Product and Services
    • 2.3.4 Cayman Chemical Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Cayman Chemical Recent Developments/Updates
  • 2.4 LifeSpan BioSciences
    • 2.4.1 LifeSpan BioSciences Details
    • 2.4.2 LifeSpan BioSciences Major Business
    • 2.4.3 LifeSpan BioSciences Lumiracoxib Product and Services
    • 2.4.4 LifeSpan BioSciences Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 LifeSpan BioSciences Recent Developments/Updates
  • 2.5 BioVision
    • 2.5.1 BioVision Details
    • 2.5.2 BioVision Major Business
    • 2.5.3 BioVision Lumiracoxib Product and Services
    • 2.5.4 BioVision Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 BioVision Recent Developments/Updates
  • 2.6 Biosynth Carbosynth
    • 2.6.1 Biosynth Carbosynth Details
    • 2.6.2 Biosynth Carbosynth Major Business
    • 2.6.3 Biosynth Carbosynth Lumiracoxib Product and Services
    • 2.6.4 Biosynth Carbosynth Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Biosynth Carbosynth Recent Developments/Updates
  • 2.7 BOC Sciences
    • 2.7.1 BOC Sciences Details
    • 2.7.2 BOC Sciences Major Business
    • 2.7.3 BOC Sciences Lumiracoxib Product and Services
    • 2.7.4 BOC Sciences Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 BOC Sciences Recent Developments/Updates
  • 2.8 Key Organics
    • 2.8.1 Key Organics Details
    • 2.8.2 Key Organics Major Business
    • 2.8.3 Key Organics Lumiracoxib Product and Services
    • 2.8.4 Key Organics Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Key Organics Recent Developments/Updates
  • 2.9 Santa Cruz Biotechnology
    • 2.9.1 Santa Cruz Biotechnology Details
    • 2.9.2 Santa Cruz Biotechnology Major Business
    • 2.9.3 Santa Cruz Biotechnology Lumiracoxib Product and Services
    • 2.9.4 Santa Cruz Biotechnology Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Santa Cruz Biotechnology Recent Developments/Updates
  • 2.10 AbMole
    • 2.10.1 AbMole Details
    • 2.10.2 AbMole Major Business
    • 2.10.3 AbMole Lumiracoxib Product and Services
    • 2.10.4 AbMole Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 AbMole Recent Developments/Updates
  • 2.11 Biorbyt
    • 2.11.1 Biorbyt Details
    • 2.11.2 Biorbyt Major Business
    • 2.11.3 Biorbyt Lumiracoxib Product and Services
    • 2.11.4 Biorbyt Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Biorbyt Recent Developments/Updates
  • 2.12 Clearsynth
    • 2.12.1 Clearsynth Details
    • 2.12.2 Clearsynth Major Business
    • 2.12.3 Clearsynth Lumiracoxib Product and Services
    • 2.12.4 Clearsynth Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Clearsynth Recent Developments/Updates
  • 2.13 LGC
    • 2.13.1 LGC Details
    • 2.13.2 LGC Major Business
    • 2.13.3 LGC Lumiracoxib Product and Services
    • 2.13.4 LGC Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 LGC Recent Developments/Updates
  • 2.14 LKT Laboratories
    • 2.14.1 LKT Laboratories Details
    • 2.14.2 LKT Laboratories Major Business
    • 2.14.3 LKT Laboratories Lumiracoxib Product and Services
    • 2.14.4 LKT Laboratories Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 LKT Laboratories Recent Developments/Updates
  • 2.15 Ark Pharm
    • 2.15.1 Ark Pharm Details
    • 2.15.2 Ark Pharm Major Business
    • 2.15.3 Ark Pharm Lumiracoxib Product and Services
    • 2.15.4 Ark Pharm Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Ark Pharm Recent Developments/Updates
  • 2.16 Aladdin
    • 2.16.1 Aladdin Details
    • 2.16.2 Aladdin Major Business
    • 2.16.3 Aladdin Lumiracoxib Product and Services
    • 2.16.4 Aladdin Lumiracoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Aladdin Recent Developments/Updates

3 Competitive Environment: Lumiracoxib by Manufacturer

  • 3.1 Global Lumiracoxib Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Lumiracoxib Revenue by Manufacturer (2018-2023)
  • 3.3 Global Lumiracoxib Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Lumiracoxib by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Lumiracoxib Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Lumiracoxib Manufacturer Market Share in 2022
  • 3.5 Lumiracoxib Market: Overall Company Footprint Analysis
    • 3.5.1 Lumiracoxib Market: Region Footprint
    • 3.5.2 Lumiracoxib Market: Company Product Type Footprint
    • 3.5.3 Lumiracoxib Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Lumiracoxib Market Size by Region
    • 4.1.1 Global Lumiracoxib Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Lumiracoxib Consumption Value by Region (2018-2029)
    • 4.1.3 Global Lumiracoxib Average Price by Region (2018-2029)
  • 4.2 North America Lumiracoxib Consumption Value (2018-2029)
  • 4.3 Europe Lumiracoxib Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Lumiracoxib Consumption Value (2018-2029)
  • 4.5 South America Lumiracoxib Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Lumiracoxib Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Lumiracoxib Sales Quantity by Type (2018-2029)
  • 5.2 Global Lumiracoxib Consumption Value by Type (2018-2029)
  • 5.3 Global Lumiracoxib Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Lumiracoxib Sales Quantity by Application (2018-2029)
  • 6.2 Global Lumiracoxib Consumption Value by Application (2018-2029)
  • 6.3 Global Lumiracoxib Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Lumiracoxib Sales Quantity by Type (2018-2029)
  • 7.2 North America Lumiracoxib Sales Quantity by Application (2018-2029)
  • 7.3 North America Lumiracoxib Market Size by Country
    • 7.3.1 North America Lumiracoxib Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Lumiracoxib Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Lumiracoxib Sales Quantity by Type (2018-2029)
  • 8.2 Europe Lumiracoxib Sales Quantity by Application (2018-2029)
  • 8.3 Europe Lumiracoxib Market Size by Country
    • 8.3.1 Europe Lumiracoxib Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Lumiracoxib Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Lumiracoxib Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Lumiracoxib Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Lumiracoxib Market Size by Region
    • 9.3.1 Asia-Pacific Lumiracoxib Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Lumiracoxib Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Lumiracoxib Sales Quantity by Type (2018-2029)
  • 10.2 South America Lumiracoxib Sales Quantity by Application (2018-2029)
  • 10.3 South America Lumiracoxib Market Size by Country
    • 10.3.1 South America Lumiracoxib Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Lumiracoxib Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Lumiracoxib Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Lumiracoxib Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Lumiracoxib Market Size by Country
    • 11.3.1 Middle East & Africa Lumiracoxib Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Lumiracoxib Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Lumiracoxib Market Drivers
  • 12.2 Lumiracoxib Market Restraints
  • 12.3 Lumiracoxib Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Lumiracoxib and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Lumiracoxib
  • 13.3 Lumiracoxib Production Process
  • 13.4 Lumiracoxib Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Lumiracoxib Typical Distributors
  • 14.3 Lumiracoxib Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Lumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1.
    According to our (Global Info Research) latest study, the global Lumiracoxib market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Lumiracoxib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Lumiracoxib market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Lumiracoxib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Lumiracoxib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Lumiracoxib market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (K USD/Kg), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Lumiracoxib
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Lumiracoxib market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Selleck Chemicals, Abcam, Cayman Chemical, LifeSpan BioSciences and BioVision, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Lumiracoxib market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Min Purity Less Than 98%
    Min Purity 98%-99%
    Min Purity More Than 99%
    Market segment by Application
    Research
    Medical
    Major players covered
    Selleck Chemicals
    Abcam
    Cayman Chemical
    LifeSpan BioSciences
    BioVision
    Biosynth Carbosynth
    BOC Sciences
    Key Organics
    Santa Cruz Biotechnology
    AbMole
    Biorbyt
    Clearsynth
    LGC
    LKT Laboratories
    Ark Pharm
    Aladdin
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Lumiracoxib product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Lumiracoxib, with price, sales, revenue and global market share of Lumiracoxib from 2018 to 2023.
    Chapter 3, the Lumiracoxib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Lumiracoxib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Lumiracoxib market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Lumiracoxib.
    Chapter 14 and 15, to describe Lumiracoxib sales channel, distributors, customers, research findings and conclusion.

    Buy now